a nonsignificant trendP = 0.1865
VAT area declined by –12.31 (IQR, 61.53) in MAKE patients and by –1.11% (IQR, 50.63) in the stable group, showing a nonsignificant trend toward greater VAT loss in MAKE ( P = 0.1865; Figure 3 D).
VAT area declined by –12.31 (IQR, 61.53) in MAKE patients and by –1.11% (IQR, 50.63) in the stable group, showing a nonsignificant trend toward greater VAT loss in MAKE ( P = 0.1865; Figure 3 D).
The proportion of allocations within the Eurotransplant Senior Program was numerically higher in the MAKE group compared with the non-MAKE group (44.0% versus 27.6%), although this difference did not reach statistical significance ( P = 0.26).